NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines

Medicines Policies

Medicine Policies

 

NHS Greater Glasgow and Clyde Area Drug and Therapeutics Committee

Policies Relating to the Management of Medicines

Policies relating to the management of medicines, and the terms of reference of ADTC and other group in the medicines advisory structure are noted in this section.  The information contained at this site is issued on the understanding that it is the best available from the resources at our disposal at the time of issue.



Expiry Date or Comments
1.1 Medicines Advisory Structure Under review
  ADTC and Subcommittees  
2.1 Area Drug and Therapeutics Committee: Terms of Reference December 2018
2.2 Formulary and New Drugs Subcommittee: Terms of Reference November 2018
2.3 Medicines Utilisation Subcommittee: Terms of Reference November 2018
2.4 Therapeutic Subcommittee: Terms of Reference Under review
2.5 Communications Subcommittee: Terms of Reference Under review
2.6 Antimicrobial Utilisation Subcommittee: Terms of Reference November 2018
2.7 Safer Use of Medicines Subcommittee: Terms of Reference Under review 
2.8 Prescribing Interface Subcommittee: Terms of Reference September 2018
  Prescribing Management Group (PMG) and Subgroups  
 3.1 Prescribing Management Group: Terms of Reference Under revew 
 3.2 Acute Services PMG: Terms of Reference Under review 
 3.3 Primary Care PMG: Terms of Reference March 2018 
 3.4  PMG Finance Subgroup: Terms of Reference Under review
  Formulary Processes  
4.1 Managed Introduction of New Medicines Under review
4.2 Managed Introduction of New Oncology Medicines Under review
4.3 Formulary Appeals and Requests for Formulary Amendments Under review
4.4 Process for conducting a review of a Formulary section  Under review 
4.5 Formulary process for non-prescription medicines and medical devices  Under review 
  Non-Formulary Processes   
5.1 Non-Formulary Prescribing Policy  Under review 
5.2  Management of Individual Patient Treatment Requests (IPTRs) January 2019
5.2.1 Briefing notes for consultants submitting an IPTR Under review
5.2.2 Briefing notes for specialist advisors supporting IPTR panels Under review
5.2.3 Brefing notes for Lead Clinical Pharmacists supporting IPTR panels Under review
5.3 Individual Patient Treatment Request (IPTR) Appeal process  January 2019
5.4 Peer Approved Clinical Systems (PACS) Policy December 2018
5.5 Co-payment Policy for patients recieving aspects of care privately Under review
   Production of Clinical Guidelines  
7.1 Clinical Guidelines Framework Via StaffNet 
7.2 'How To' guides for Clinical Guideline development Via StaffNet 
7.3  Electronic Checklist for submission of Clinical Guidelines Via StaffNet
7.4  AUC Antimicrobial Guideline Approval Process  Under review 
7.5  AUC Antimicrobial Guideline Approval Process (Algorithm) Under review 
7.6  AUC Antimicrobial Guideline Checklist   Under review 
  Therapeutics Subcommittee Policies  
8.1 Non-medical Prescribing Policy  Under review 
8.2  Processes related to the Therapeutics Formularies  Under review 
  Unlicensed Medicines   
9.1  Acute Unlicensed Medicines Policy (ULM Policy) Under review 
9.2  ULM Policy Frequently Asked Questions  Under review 
9.3  Expanded Access / Compassionate Use / Named Patient Supply Programmes for Unlicensed Medicines  December 2016 
  Medicines Reconciliation   
10.1  Medicines Reconciliation in Hospital  March 2018 
  Clinical and Handling of Medicines Policies  
11.1 Safe and Secure Handling of Medicines Policy (Primary Care) Under review 
11.2 Safe and Secure Handling of Medicines Policy (Acute Division) Under review
11.3 Intravenous Flush Policy (Acute Division) December 2017
11.4  Intrathecal Chemotherapy Policy  Under review 
11.5  Policy for Non-Cytotoxic Intrathecal and Intraventricular Injections July 2017
11.5.1 Register of Authorised Non-Cytotoxic Intrathecal and Intracentricular Injections (December 2016) -
11.6 Suspected Medicines Defect Policy March 2018
11.6.1 Suspected Medicines Defect Reporting Form (for use by acute pharmacy staff)  
  Other Medicines Policies  
12.1 Supply of Medicines Following Specialist Review or Clinic Appointments October 2017
12.1.1 Supply of Medicines Following Specialist Review - Additional Guidance for Mental Health August 2019